+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea



Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea



Lung 186(4): 209-217



Obesity is the major confounding factor in the relationship between obstructive sleep apnea and increased risk for cardiovascular disease. The aim of the study was to investigate the association of sleep apnea severity with insulin resistance, leptin, and CRP levels in a cohort of male patients. Sixty-seven men referred to our sleep laboratory for evaluation of suspected obstructive sleep apnea syndrome (OSAS) were divided into three groups according to apnea severity: non-OSAS group (n=15), mild to moderate OSAS group (n=26), and severe OSAS (n=26). Insulin resistance was estimated by the homeostasis model assessment method. HOMA values were similar in the three groups: (3.2+/-2.2 vs. 3.3+/-1.8 vs. 3.6+/-1.5, respectively, p=0.71). Leptin levels were higher in the mild to moderate OSAS group (23.1+/-21.8 ng/ml, p<0.05) and in the severe OSAS group (20.2+/-17.5 ng/ml, p<0.05) than in the non-OSAS group (9.4+/-6.4 ng/ml). CRP levels were significantly higher in severe sleep apnea (0.35+/-0.3 vs. 0.19+/-0.1 mg/dl, p<0.05). In multiple regression analyses, waist-to-hip ratio (WHR) was the most significant determinant of HOMA estimation for insulin resistance. WHR and the percentage of total sleep time spent with hypoxemia (%TST with SaO2 <90%) were significant predictors for leptin levels, while body mass index (BMI) and the %TST with SaO2 <90% were the best predicting parameters for CRP levels. Insulin resistance estimated by the HOMA method in male patients with OSAS was not associated with sleep apnea severity independent of obesity. The severity of nocturnal hypoxemia was associated with leptin and CRP levels independent of obesity.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 030208943

Download citation: RISBibTeXText

PMID: 18365276

DOI: 10.1007/s00408-008-9082-x


Related references

The association of obesity with insulin resistance in male patients with obstructive sleep apnea syndrome in Korea. Psychiatry Investigation 8(3): 245-249, 2011

The role of obesity, different fat compartments and sleep apnea severity in circulating leptin levels the Icelandic Sleep Apnea Cohort study. International Journal of Obesity 37(6): 835-842, 2013

The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort. Sleep 35(7): 921-932, 2012

Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Annals of Thoracic Medicine 6(3): 120-125, 2011

The association of the severity of obstructive sleep apnea with plasma leptin levels. Archives of Otolaryngology--Head and Neck Surgery 129(5): 538-540, 2003

Association of elevated levels of vascular endothelial growth factor in obstructive sleep apnea syndrome with patient age rather than with obstructive sleep apnea syndrome severity. Respiration; International Review of Thoracic Diseases 74(1): 50-55, 2006

Obstructive sleep apnea in epilepsy patients: the Sleep Apnea scale of the Sleep Disorders Questionnaire (SA-SDQ) is a useful screening instrument for obstructive sleep apnea in a disease-specific population. Sleep Medicine 4(6): 517-521, 2003

Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. American Journal of Medicine 117(2): 118-121, 2004

Can we truly change from polysomnography to polygraphy in obstructive sleep apnea? A comparison between these to levels of sleep studies in a population of patients with obstructive sleep apnea. Sleep Medicine 40: E258-E259, 2017

Elevated plasma C-reactive protein and increased cardiovascular/cerebrovascular risk in sleep apnea patients. Article reviewed: Elevated C-reactive protein in patients with obstructive sleep apnea (a brief rapid communication). Sleep Medicine 3(5): 449-450, 2003

Reply: "Obstructive Sleep Apnea, Sleep Duration, and Fasting Glucose" and "The Impact of Obesity on the Association between Obstructive Sleep Apnea and Glucose Metabolism". American Journal of Respiratory and Critical Care Medicine 193(5): 580-581, 2016

The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea. Sleep and Breathing 16(1): 217-221, 2012

Relationship between the severity of obstructive sleep apnea and impaired glucose metabolism in patients with obstructive sleep apnea. Respiratory Medicine 102(10): 1412-1416, 2008

Association of osteopontin and tumor necrosis factor-α levels with insulin resistance in obese patients with obstructive sleep apnea syndrome. Journal of Endocrinological Investigation 34(7): 528-533, 2012

The effect of sleep apnea severity on cardiac autonomic activity during night time in obstructive sleep apnea patients. Sao Paulo Medical Journal 134(5): 430-436, 2016